Literature DB >> 17639553

Antidepressant and antistress activity of GC-MS characterized lipophilic extracts of Ginkgo biloba leaves.

Satyan S Kalkunte1, Ajay P Singh, Fabio C Chaves, Thomas J Gianfagna, Vishal S Pundir, Arun K Jaiswal, Nicholi Vorsa, Surendra Sharma.   

Abstract

Lipophilic extracts of Ginkgo biloba L. leaves were tested for their possible role on rodent models of depression and stress. Lipophilic extracts of Ginkgo leaves (LEG) at (50 and 100 mg/kg, p.o.) exhibited dose dependent, significant antidepressant activity in the behavioral despair test and learned helplessness rodent model of depression. The activities were comparable to that of imipramine (15 mg/kg) and EGb 761 (50 mg/kg). In the cold immobilization stress induced gastric ulcer model of stress, only the LEG showed a significant reduction in the ulcer index. GC-MS characterization of this bioactive extract was found to be rich in a group of 6-alkyl salicylates (6-AS), along with a fatty alcohol, fatty acids and cardanols. The n-heptadecenyl salicylate represented 60% of the 6-AS. Notable was the absence of dihydroxy alkylphenols which are linked to allergic reactions similar to the urushiols present in poison ivy. In commercial products of Ginkgo, these dihydroxy phenols as well as the favorable 6-AS are removed during enrichment of flavonol glycosides and terpenic lactones. The current findings suggest that intact carboxylic acid groups containing 6-AS are the bioactive components of the lipophilic extract of Ginkgo leaves with antidepressant and antistress activities. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639553     DOI: 10.1002/ptr.2212

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

2.  Antidepressant properties of bioactive fractions from the extract of Crocus sativus L.

Authors:  Yang Wang; Ting Han; Yu Zhu; Cheng-Jian Zheng; Qian-Liang Ming; Khalid Rahman; Lu-Ping Qin
Journal:  J Nat Med       Date:  2009-09-29       Impact factor: 2.343

3.  Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice.

Authors:  Yan Hou; Marwa A Aboukhatwa; De-Liang Lei; Kebreten Manaye; Ikhlas Khan; Yuan Luo
Journal:  Neuropharmacology       Date:  2009-11-14       Impact factor: 5.250

4.  Effects of ginkgoneolic acid on the growth, acidogenicity, adherence, and biofilm of Streptococcus mutans in vitro.

Authors:  Jinzhi He; Shida Wang; Tingxi Wu; Yangpei Cao; Xin Xu; Xuedong Zhou
Journal:  Folia Microbiol (Praha)       Date:  2012-09-06       Impact factor: 2.099

5.  Anti-Cancer Properties of Ginkgolic Acids in Human Nasopharyngeal Carcinoma CNE-2Z Cells via Inhibition of Heat Shock Protein 90.

Authors:  Hong-Mei Li; Hui Ma; Xiaolong Sun; Bohan Li; Chengjiang Cao; Yiqun Dai; Meilin Zhu; Cheng-Zhu Wu
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

6.  Selective potentiation of alpha 1 glycine receptors by ginkgolic acid.

Authors:  Galyna Maleeva; Svetlana Buldakova; Piotr Bregestovski
Journal:  Front Mol Neurosci       Date:  2015-10-29       Impact factor: 5.639

7.  Evaluation of the Anxiolytic and Antidepressant Activities of the Aqueous Extract from Camellia euphlebia Merr. ex Sealy in Mice.

Authors:  Dongye He; Xitao Wang; Ping Zhang; Xinxing Luo; Xiaoyu Li; Lili Wang; Shuying Li; Yongping Xu
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-01       Impact factor: 2.629

8.  Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4.

Authors:  Ke Liu; Xinhuan Wang; Duo Li; Dongyang Xu; Dezhi Li; Zhiyong Lv; Dan Zhao; Wen-Feng Chu; Xiao-Feng Wang
Journal:  Mol Ther Oncolytics       Date:  2019-12-14       Impact factor: 7.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.